Nanocarriers in Neurodegenerative Disorders: Therapeutic Hopes and Hypes
Podrobnosti o e‑knize
Key Features
- Provides a comparative perspective of various nanocarrier systems, therefore facilitating the researcher's selection of appropriate nanoparticulate carriers
- Highlights the related restrictions of brain delivery and current available medicines
- Includes information on the advantages and disadvantages of various biomaterials utilized in the development of nanocarriers for brain targeting
- Emphasizes distinct facets of surface functionalization according to the brain area of interest
- Presents the current advances, preclinical and clinical development, and the future potential of multiple brain-targeting technologies
O autorovi
Dr. Wael Mohamed Yousef Mohamed, a Physician Neuroscientist, earned his PhD from PSU in the USA and currently holds the position of Associate Professor at IIUM Medical School in Malaysia. With an extensive background, Dr. Mohamed has been invited to deliver over 150 lectures both domestically and internationally. His contributions to Neuroscience/Psychiatry are notable, with the publication of more than 100 peer-reviewed papers, boasting an h-index of 20. Furthermore, Dr. Mohamed serves as an editor for Frontiers in Neurology and PLOS-ONE Journals, where he has contributed to various journal special issues on brain disorders. In the realm of book editing, he is actively involved with Springer, CRC, and Cambridge in the field of neuroscience. His research endeavors have attracted numerous grants from esteemed national and international organizations, including IBRO, ISN, MJF, STDF, FRGS, and INDO-ASEAN, amounting to a total research funding of half a million US$. Notably, he is the founder and chair of the AfrAbia-PD-Genomic Consortium.
